Table 3. Median value (and 95% confidence interval) of leukocyte cell population data (CPD) in patients admitted to the intensive care unit (ICU) with or without liver dysfunction.
| Parameters | Patients without liver dysfunction | Patients with liver dysfunction | |||||
|---|---|---|---|---|---|---|---|
| No sepsis | Sepsis | Septic shock | No sepsis | Sepsis | Septic shock | ||
| NE-SSC | 151.6§ (151.1–152.0) | 151.9£ (150.2–153.3) | 153.7 (152.4–154.7) | 150.4 (149.0–152.6) | 153.8 (145.7–154.7) | 154.2 (151.0–156.4) | |
| NE-WX | 324.0* (321.0–327.0) | 329.0 (324.0–335.0) | 323.0 (313.0–359.0) | 344.5 (330.0–358.0) | 328.0 (323.0–337.0) | 331.5 (322.0–343.0) | |
| NE-SFL | 55.7§ (55.1–56.2) | 57.3£ (54.4–59.3) | 60.5 (58.8–66.3) | 55.8§ (54.6–56.7) | 57.5£ (54.5–58.8) | 62.4 (57.9–65.5) | |
| NE-WY | 649.0§* (644.0–655.0) | 657.5£* (648.0–678.0) | 764.0 (706.0–886.0) | 715.5 (697.0–777.0) | 713.0 (688.0–752.0) | 765.5 (701.0–812.0) | |
| NE-FSC | 87.9& (87.3–88.8) | 87.3* (86.4–88.0) | 87.5 (86.3–89.0) | 88.3 (87.0–90.4) | 89.6 (86.3–92.7) | 90.0 (87.3–92.5) | |
| NE-WZ | 736.5&§ (722.0–755.0) | 755.6£ (741.6–769.6) | 788.4 (764.6–812.3) | 770.5 (721.0–789.0) | 772.0 (675.0–826.0) | 763.5 (712.0–816.0) | |
| LY-X | 83.1& (82.8–83.3) | 83.7 (83.3–84.1) | 83.1* (81.0–84.2) | 82.3 (81.8–83.3) | 84.8 (81.0–85.7) | 86.1 (85.6–86.8) | |
| LY-WX | 474.5§ (468.0–481.0) | 485.0£ (477.0–497.0) | 547.0* (505.0–599.0) | 469.0 (445.0–525.0) | 456.0 (442.0–531.0) | 490.0 (452.0–553.0) | |
| LY-Y | 77.7§* (77.1–78.4) | 76.8£* (75.9–79.0) | 69.5* (56.8–81.0) | 74.8§ (73.0–76.2) | 74.2£ (70.2–76.4) | 88.6 (84.4–92.2) | |
| LY-WY | 900.0&§ (886.0–919.0) | 968.5* (926.0–1,002.0) | 1,013.0 (917.0–1,169.0) | 925.0& (878.0–959.0) | 1,060.0 (1,019.0–1,111.0) | 976.0 (859.0–1,067.0) | |
| LY-Z | 59.3§ (58.9–59.7) | 59.6£ (59.1–60.7) | 57.3* (54.8–59.6) | 59.6 (58.9–60.9) | 58.6 (57.1–60.3) | 60.3 (59.4–61.4) | |
| LY-WZ | 602.0 (592.0–608.0) | 628.0 (605.0–650.0) | 690.0* (606.0–1,006.0) | 595.0 (544.0–626.0) | 643.0 (574.0–666.0) | 625.5 (585.0–737.0) | |
| MO-X | 123.6&§* (123.3–124.0) | 124.6£ (123.5–125.3) | 126.5* (125.3–127.5) | 122.7&§ (121.7–123.6) | 124.8 (123.5–126.1) | 127.9 (127.0–129.0) | |
| MO-WX | 258.0§ (255.0–262.0) | 263.0£ (257.0–269.0) | 287.0* (262.0–307.0) | 253.5& (247.0–271.0) | 274.0 (263.0–288.0) | 261.0 (251.0–268.0) | |
| MO-Y | 120.4 (119.5–121.5) | 118.8 (117.3–120.9) | 116.1* (112.2–124.6) | 118.0§ (115.6–121.2) | 118.5 (114.5–121.8) | 128.9 (126.6–135.1) | |
| MO-WY | 722.0 (709.0–734.0) | 755.5* (739.0–770.0) | 698.0* (613.0–778.0) | 724.5&§ (675.0–738.0) | 810.0 (773.0–849.0) | 771.0 (742.0–832.0) | |
| MO-Z | 61.4 (60.9–61.9) | 60.8 (59.9–61.6) | 62.3* (60.7–63.3) | 62.3&§ (61.3–63.2) | 60.7 (58.2–61.6) | 58.5 (57.4–60.0) | |
| MO-WZ | 727.5* (708.0–745.0) | 760.5 (731.0–786.0) | 787.0 (742.0–827.0) | 687.5§ (647.0–706.0) | 706.0 (637.0–797.0) | 782.0 (728.0–850.0) | |
Statistically significant difference by Steel-Dwass-Critchlow-Fligner and by Kruskal-Wallis test with P<0.01. &, no sepsis versus sepsis; §, no sepsis versus septic shock; £, sepsis versus septic shock; *, patients without liver dysfunction versus patients with liver dysfunction in the same class of parameters. The full name of parameters are described in Table 1.